Characteristics of the 78 patients with acute myeloid leukemia (AML) receiving dynamic contrast-enhanced magnetic resonance image (DCE-MRI)
| Variable . | No. of patients (%) . |
|---|---|
| Male | 37 (47) |
| Female | 41 (53) |
| Age, y* | 49 (17-76) |
| FAB classification* | |
| M0 | 1 (1.3) |
| M1 | 16 (20.5) |
| M2 | 31 (39.8) |
| M3 | 5 (6.4) |
| M4 | 16 (20.5) |
| M5 | 4 (5.1) |
| M6 | 4 (5.1) |
| Unclassified | 1 (1.3) |
| Karyotype† | |
| Favorable | 14 (18.0) |
| Intermediate | 52 (66.7) |
| Unfavorable | 10 (12.8) |
| Unknown | 2 (2.5) |
| Follow-up, mo* | 16.2 (4-34.3) |
| CR | 57 (73.1) |
| CR duration, mo* | 9.0 (1-33.4) |
| Overall survival, mo* | 11.3 (0.4-34.3) |
| Variable . | No. of patients (%) . |
|---|---|
| Male | 37 (47) |
| Female | 41 (53) |
| Age, y* | 49 (17-76) |
| FAB classification* | |
| M0 | 1 (1.3) |
| M1 | 16 (20.5) |
| M2 | 31 (39.8) |
| M3 | 5 (6.4) |
| M4 | 16 (20.5) |
| M5 | 4 (5.1) |
| M6 | 4 (5.1) |
| Unclassified | 1 (1.3) |
| Karyotype† | |
| Favorable | 14 (18.0) |
| Intermediate | 52 (66.7) |
| Unfavorable | 10 (12.8) |
| Unknown | 2 (2.5) |
| Follow-up, mo* | 16.2 (4-34.3) |
| CR | 57 (73.1) |
| CR duration, mo* | 9.0 (1-33.4) |
| Overall survival, mo* | 11.3 (0.4-34.3) |